Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. https://doi.org/10.3322/caac.21708.

Article  PubMed  Google Scholar 

Cellini F, Tagliaferri L, Frascino V, Alitto AR, Fionda B, Boldrini L, Romano A, Casà C, Catucci F, Mattiucci GC, et al. Radiation therapy for prostate cancer: what’s the best in 2021. Urol J. 2022;89:5–15. https://doi.org/10.1177/03915603211042335.

Article  Google Scholar 

National Comprehensive Cancer Network. Prostate cancer (Version 2.2021). (2021) https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.

Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, Tombal B, Gillessen S. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1119–34. https://doi.org/10.1016/j.annonc.2020.06.011.

Article  CAS  PubMed  Google Scholar 

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62. https://doi.org/10.1016/j.eururo.2020.09.042.

Article  CAS  PubMed  Google Scholar 

Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer. Part II-2020 update: treatment of relapsing and metastatic prostate Cancer. Eur Urol. 2021;79:263–82. https://doi.org/10.1016/j.eururo.2020.09.046.

Article  CAS  PubMed  Google Scholar 

Sanda MG, Chen RC, Crispino T, Freedland S, Greene K, Klotz LH, Makarov DV, Reston J, Rodrigues G, Sandler HM et al. Clinically localized prostate cancer: AUA/ASTRO/SUO GUIDELINE. Prostate Cancer (2017)56.

Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment. Pract Radiat Oncol. 2015;5:e615–23. https://doi.org/10.1016/j.prro.2015.04.009.

Article  PubMed  Google Scholar 

Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965–74. https://doi.org/10.1016/j.ijrobp.2006.04.029.

Article  PubMed  Google Scholar 

Priore GD, Hoffman S. Timing of androgen-deprivation therapy in prostate cancer. Lancet Oncol. 2017;18:e633. 1470-2045(17)30774-X.

Article  PubMed  Google Scholar 

Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L, Montorsi F, van Poppel H, Scardino PT, Shariat SF. Cancer Control and Functional Outcomes of Salvage Radical Prostatectomy for Radiation-recurrent prostate Cancer: a systematic review of the literature. Eur Urol. 2012;61:961–71. https://doi.org/10.1016/j.eururo.2012.01.022.

Article  PubMed  Google Scholar 

Philippou Y, Parker RA, Volanis D, Gnanapragasam VJ. Comparative oncologic and toxicity outcomes of Salvage Radical Prostatectomy Versus Nonsurgical Therapies for Radiorecurrent prostate Cancer: a Meta–regression analysis. Eur Urol Focus. 2016;2:158–71. https://doi.org/10.1016/j.euf.2015.09.004.

Article  PubMed  Google Scholar 

Parekh A, Graham PL, Nguyen PL. Cancer Control and Complications of Salvage Local Therapy after failure of Radiotherapy for prostate Cancer: a systematic review. Semin Radiat Oncol. 2013;23:222–34. https://doi.org/10.1016/j.semradonc.2013.01.006.

Article  PubMed  Google Scholar 

Ingrosso G, Becherini C, Lancia A, Caini S, Ost P, Francolini G, Høyer M, Bottero M, Bossi A, Zilli T, et al. Nonsurgical salvage local therapies for radiorecurrent prostate Cancer: a systematic review and Meta-analysis. Eur Urol Oncol. 2020;3:183–97. https://doi.org/10.1016/j.euo.2018.12.011.

Article  PubMed  Google Scholar 

Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, et al. A systematic review and Meta-analysis of local salvage therapies after radiotherapy for prostate Cancer (MASTER). Eur Urol. 2021;80:280–92. https://doi.org/10.1016/j.eururo.2020.11.010.

Article  PubMed  Google Scholar 

Chatzikonstantinou G, Zamboglou N, Rödel C, Zoga E, Strouthos I, Butt SA, Tselis N. High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy: a systematic review. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2017;193:683–91. https://doi.org/10.1007/s00066-017-1157-2.

Article  Google Scholar 

Munoz F, Fiorica F, Caravatta L, Rosa C, Ferella L, Boldrini L, Fionda B, Alitto AR, Nardangeli A, Dionisi F, et al. Outcomes and toxicities of re-irradiation for prostate cancer: a systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Cancer Treat Rev. 2021;95:102176. https://doi.org/10.1016/j.ctrv.2021.102176.

Article  CAS  PubMed  Google Scholar 

Abusaris H, Hoogeman M, Nuyttens JJ, Re-Irradiation. Outcome, cumulative dose and toxicity in patients retreated with stereotactic Radiotherapy in the abdominal or pelvic region. Technol Cancer Res Treat. 2012;11:591–7. https://doi.org/10.7785/tcrt.2012.500261.

Article  PubMed  Google Scholar 

Catucci F, Alitto AR, Masciocchi C, Dinapoli N, Gatta R, Martino A, Mazzarella C, Fionda B, Frascino V, Piras A et al. Predicting Radiotherapy Impact on Late Bladder Toxicity in Prostate Cancer Patients: An Observational Study. Cancers (2021) 13:E175. doi: https://doi.org/10.3390/cancers13020175.

Vavassori A, Jereczek-Fossa BA, Beltramo G, De Cicco L, Fariselli L, Bianchi LC, Possanzini M, Bergantin A, DeCobelli O, Orecchia R. Image-guided robotic Radiosurgery as Salvage Therapy for locally recurrent prostate Cancer after External Beam Irradiation: Retrospective Feasibility Study on six cases. Tumori J. 2010;96:71–5. https://doi.org/10.1177/030089161009600112.

Article  Google Scholar 

Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, Bonucci I, Franceschini D, Di Brina L, Baki M, et al. CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed. World J Urol. 2016;34:311–7. https://doi.org/10.1007/s00345-015-1613-5.

Article  CAS  PubMed  Google Scholar 

Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, Volpe S, Luraschi R, Bazani A, Rondi E, et al. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT). Br J Radiol. 2019;92:20180494. https://doi.org/10.1259/bjr.20180494.

Article  PubMed  Google Scholar 

Fuller D, Wurzer J, Shirazi R, Bridge S, Law J, Crabtree T, Mardirossian G. Retreatment for local recurrence of Prostatic Carcinoma after prior therapeutic irradiation: efficacy and toxicity of HDR-Like SBRT. Int J Radiat Oncol Biol Phys. 2020;106:291–9. https://doi.org/10.1016/j.ijrobp.2019.10.014.

Article  CAS  PubMed  Google Scholar 

Tetar SU, Bruynzeel AME, Oei SS, Senan S, Fraikin T, Slotman BJ, van Moorselaar RJA, Lagerwaard FJ. Magnetic resonance-guided stereotactic radiotherapy for localized prostate Cancer: final results on patient-reported outcomes of a prospective phase 2 study. Eur Urol Oncol. 2021;4:628–34. https://doi.org/10.1016/j.euo.2020.05.007.

Article  PubMed  Google Scholar 

Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F, Debus J, Guckenberger M, Hörner-Rieber J, Lagerwaard FJ, et al. MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol. 2019;14:92. https://doi.org/10.1186/s13014-019-1308-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boldrini L, Corradini S, Gani C, Henke L, Hosni A, Romano A, Dawson L. MR-Guided Radiotherapy for Liver Malignancies. Front Oncol. 2021;11:616027. https://doi.org/10.3389/fonc.2021.616027.

Article  PubMed  PubMed Central  Google Scholar 

Corradini S, Alongi F, Andratschke N, Azria D, Bohoudi O, Boldrini L, Bruynzeel A, Hörner-Rieber J, Jürgenliemk-Schulz I, Lagerwaard F, et al. ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;159:146–54. https://doi.org/10.1016/j.radonc.2021.03.025.

Article  Google Scholar 

Bruynzeel AME, Tetar SU, Oei SS, Senan S, Haasbeek CJA, Spoelstra FOB, Piet AHM, Meijnen P, van der Jagt MABB, Fraikin T, et al. A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive Radiation therapy for prostate Cancer: early toxicity results. Int J Radiat Oncol Biol Phys. 2019;105:1086–94. https://doi.org/10.1016/j.ijrobp.2019.08.007.

Article  CAS  PubMed  Google Scholar 

Cuccia F, Rigo M, Figlia V, Giaj-Levra N, Mazzola R, Nicosia L, Ricchetti F, Trapani G, De Simone A, Gurrera D, et al. 1.5T MR-Guided daily adaptive stereotactic body radiotherapy for prostate re-irradiation: a preliminary report of toxicity and clinical outcomes. Front Oncol. 2022;12:858740. https://doi.org/10.3389/fonc.2022.858740.

Article  PubMed  PubMed Central  Google Scholar 

Michalet M, Riou O, Valdenaire S, Debuire P, Ailleres N, Draghici R, Charissoux M, Moscardo CL, Farcy-Jacquet M-P, Fenoglietto P, et al. Magnetic resonance–guided reirradiation for local recurrence within the prostate or in the prostate Bed: preliminary results of a prospective Registry Study. Adv Radiat Oncol. 2021;6:100748. https://doi.org/10.1016/j.adro.2021.100748.

Article  PubMed  PubMed Central  Google Scholar 

ICRU Report 83, Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT) – ICRU. https://www.icru.org/report/prescribing-recording-and-reporting-intensity-modulated-photon-beam-therapy-imrticru-report-83/ [Accessed June 10, [Accessed June 10, 2022].022]

Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu A-L, Moustakis C, Schmitt D, Baus WW, Guckenberger M. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2019;195:193–8. https://doi.org/10.1007/s00066-018-1416-x.

Article  Google Scholar 

D’Agostino GR, Di Brina L, Mancosu P, Franzese C, Iftode C, Franceschini D, Clerici E, Tozzi A, Navarria P, Scorsetti M. Reirradiation of locally recurrent prostate Cancer with Volumetric Modulated Arc Therapy. Int J Radiat Oncol. 2019;104:614–21. https://doi.org/10.1016/j.ijrobp.2019.02.041.

Article  Google Scholar 

Di Franco R, Borzillo V, Scipilliti E, Ametrano G, Serra M, Arrichiello C, Savino F, De Martino F, D’Alesio V, Cammarota F et al. Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation. Cancers (2022) 14:3187. doi: https://doi.org/10.3390/cancers14133187.

Common. Terminology Criteria for Adverse Events (CTCAE). (2009)79.

Common. Terminology Criteria for Adverse Events (CTCAE). (2017)155.

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47. https://doi.org/10.1016/j.ejca.2008.10.026.

Article  CAS  PubMed  Google Scholar 

Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, et al. Optimum imaging strategies for advanced prostate Cancer: ASCO Guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38:1963–96. https://doi.org/10.1200/JCO.19.02757.

Article  CAS  Google Scholar 

Piras A, Laudicella R, Boldrini L, D’Aviero A, Sanfratello A, La Rocca A, Scurria S, Salamone G, Alongi P, Angileri T et al. The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report. Life (2022) 12:1728. doi: https://doi.org/10.3390/life12111728.

Mouraviev V, Spiess PE, Jones JS. Salvage Cryoablation for locally recurrent prostate Cancer following primary Radiotherapy. Eur Urol. 2012;61:1204–11. https://doi.org/10.1016/j.eururo.2012.02.051.

Article  PubMed